2025 third_quarter Filing
Q3Income
$10K
Filed
October 20, 2025
Lobbying Activities
Health IssuesView all
General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.
Contacted:Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Office of Science & Technology Policy (OSTP), SENATE, Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES
Lobbyists (2)
MARK F LINDSAY
US House Staff
ERIK DELL